Hui Gan

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study

Barbara Burtness, Kevin J. Harrington, Richard Greil et al. · The Lancet · 2019 · 3K citations · Full text

Neoadjuvant Therapy, Chemotherapy Versus Cetuximab, Medicine +7

Glioma progression is shaped by genetic evolution and microenvironment interactions

Frederick S. Varn, Kevin C. Johnson, Jan Martínek et al. · Cell · 2022 · 455 citations · Full text

Glioma Progression, Glioma, Tumor Heterogeneity +11

Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab

Hui Gan, Arun Azad, Lawrence Cher et al. · Neuro-Oncology · 2009 · 174 citations · Full text

Lymphoid Neoplasia, Oncology, Objective Response Rate +10

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

Bruce E. Loveland, Anne Zhao, Shane White et al. · Clinical Cancer Research · 2006 · 171 citations

A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors

Jean‐Charles Soria, Hui Gan, Sarah P. Blagden et al. · Annals of Oncology · 2016 · 140 citations · Full text

Pharmacodynamic Study, Medicine, Cell Adhesion +7